Switching from Propranolol to Metoprolol Succinate
When switching from propranolol to metoprolol succinate, use a direct 2:1 dose conversion ratio (propranolol:metoprolol) and initiate metoprolol at the calculated equivalent dose on the same day you discontinue propranolol, with close monitoring of heart rate and blood pressure for the first 24-48 hours. 1
Dose Conversion Guidelines
The fundamental conversion ratio is 2:1, meaning propranolol 80 mg twice daily (160 mg/day total) converts to metoprolol 100 mg twice daily (200 mg/day total). 1 Similarly, propranolol 40 mg twice daily (80 mg/day total) converts to metoprolol 50 mg twice daily (100 mg/day total). 1
Practical Conversion Examples:
- Propranolol 160 mg/day → Metoprolol succinate 200 mg once daily 1, 2
- Propranolol 80 mg/day → Metoprolol succinate 100 mg once daily 1, 2
- Propranolol 40 mg/day → Metoprolol succinate 50 mg once daily 1, 2
The FDA label confirms that when switching from immediate-release metoprolol to metoprolol succinate extended-release, the same total daily dose should be used, and this principle applies to propranolol conversions using the 2:1 ratio. 2
Transition Methods by Clinical Setting
Stable Outpatient Patients
Discontinue propranolol and start metoprolol succinate at the calculated equivalent dose on the same day. 1 In a monitored environment, you can administer the first metoprolol dose 15 minutes after the last propranolol dose. 1
If the patient is on extended-release propranolol, initiate metoprolol succinate at the next scheduled dosing time (typically 24 hours later). 1 The extended-release formulation allows for once-daily dosing, which improves adherence. 2
Hospitalized or Acute Coronary Syndrome Patients
For patients previously receiving IV propranolol (0.5-1 mg initial bolus, then 40-80 mg orally every 6-8 hours), switch to oral metoprolol 25-50 mg every 6 hours for 48 hours, then transition to 100 mg twice daily. 1
When initiating IV metoprolol de novo, give 5 mg IV over 1-2 minutes, repeat every 5 minutes up to a total of 15 mg, then begin oral metoprolol 25-50 mg every 6 hours. 3, 4, 1
Monitoring Requirements
Monitor heart rate and blood pressure closely for the first 24-48 hours after switching. 1 Target a resting heart rate of 50-60 beats per minute unless limited by adverse effects. 1
Critical Pre-Switch Assessment:
- Do not switch if systolic blood pressure < 90 mmHg 1
- Do not switch if heart rate < 50 bpm 1
- Perform continuous ECG monitoring if PR interval > 0.24 seconds or any degree of AV block present 1
Clinical Advantages of Metoprolol Succinate
Metoprolol is β₁-selective, whereas propranolol is non-selective, making metoprolol strongly preferred in patients with chronic obstructive pulmonary disease or reactive airway disease. 3, 1 Start with low doses such as 12.5 mg orally in these patients. 1 Metoprolol is also favored in peripheral vascular disease. 1
Recent experimental evidence suggests metoprolol may have unique anti-inflammatory properties during myocardial ischemia-reperfusion injury that are not shared by other β-blockers including propranolol, though this requires clinical confirmation. 5
Absolute Contraindications to Switching
- Signs of heart failure or low-output state 1
- High risk for cardiogenic shock (age > 70 years, systolic BP < 120 mmHg, heart rate > 110 or < 60 bpm, higher Killip class) 1
- Marked first-degree AV block (PR > 0.24 seconds) or higher-grade blocks without a pacemaker 1
- Active asthma or severe reactive airway disease (contraindication for propranolol; metoprolol is safer but still requires caution) 3, 1
- Hypotension (systolic BP < 90 mmHg) 1
Titration Strategy Post-Switch
Begin with the calculated equivalent dose and titrate based on clinical response over 2-3 days. 1 For metoprolol succinate extended-release, initiate 50-200 mg once daily depending on the converted dose. 1, 2
The maximum recommended dose is metoprolol 200 mg twice daily (400 mg/day total), though doses above 400 mg per day have not been studied. 1, 2 The FDA label specifies that dosages should be individualized and the whole or half tablet should be swallowed whole, not chewed or crushed. 2
Common Pitfalls to Avoid
Never abruptly stop propranolol without transitioning to metoprolol, as this can precipitate rebound hypertension, tachycardia, or acute coronary events. 1 The switch should be seamless with no gap in β-blocker coverage.
Do not assume all β-blockers are interchangeable for specific indications. For heart failure with reduced ejection fraction, only bisoprolol, metoprolol succinate, carvedilol, and nebivolol have proven mortality benefits. 6, 7 Metoprolol tartrate (short-acting) showed inferior outcomes compared to carvedilol in one trial, but metoprolol succinate (long-acting) demonstrated a 34% reduction in all-cause mortality in MERIT-HF. 6, 7
When switching from short-acting to long-acting β-blockers in heart failure patients, one study showed this could be done safely with significant heart rate reduction, though only one-third of patients reached target doses. 8